REFERENCES

• PiomelliDThe molecular logic of endocannabinoid signallingNat Rev Neurosci2003487388414595399
   PubMed Web of Science ®Google Scholar
• KanoMOhno-ShosakuTHashimotodaniYUchigashimaMWatanabeMEndocannabinoid-mediated control of synaptic transmissionPhysiol Rev20098930938019126760
   PubMed Web of Science ®Google Scholar
• ElphickMRThe evolution and comparative neurobiology of endocannabinoid signallingPhilos Trans R Soc Lond B Biol Sci20123673201321523108540
   PubMed Web of Science ®Google Scholar
• MechoulamRParkerLAThe endocannabinoid system and the brainAnnu Rev Psychol201364214722804774
   PubMed Web of Science ®Google Scholar
• LigrestiADe PetrocellisLDi MarzoVFrom phytocannabinoids to cannabinoid receptors and endocannabinoids: pleiotropic physiological and pathological roles through complex pharmacologyPhysiol Rev2016961593165927630175
   PubMed Web of Science ®Google Scholar
• CristinoLBisognoTDi MarzoVCannabinoids and the expanded endocannabinoid system in neurological disordersNat Rev Neurol20201692931831863
   PubMed Web of Science ®Google Scholar
• LutzBMarsicanoGMaldonadoRHillardCJThe endocannabinoid system in guarding against fear, anxiety and stressNat Rev Neurosci20151670571826585799
   PubMed Web of Science ®Google Scholar
• Ruiz de AzuaILutzBMultiple endocannabinoid-mediated mechanisms in the regulation of energy homeostasis in brain and peripheral tissuesCell Mol Life Sci2019761341136330599065
   PubMed Web of Science ®Google Scholar
• MuzikODiwadkarVAHierarchical control systems for the regulation of physiological homeostasis and affect: can their interactions modulate mood and anhedonia?Neurosci Biobehav Rev201910525126131442518
   PubMed Web of Science ®Google Scholar
• PiazzaPVCotaDMarsicanoGThe CB1 Receptor as the cornerstone of exostasisNeuron2017931252127428334603
   PubMed Web of Science ®Google Scholar
• NavarreteFGarcia-GutierrezMSJurado-BarbaRet alEndocannabinoid system components as potential biomarkers in psychiatryFront Psychiatry20201131532395111
   PubMed Web of Science ®Google Scholar
• RiebeCJWotjakCTEndocannabinoids and stressStress20111438439721663537
   PubMed Web of Science ®Google Scholar
• CinarRIyerMRKunosGThe therapeutic potential of second and third generation CB1R antagonistsPharmacol Ther202020810747731926199
   PubMed Web of Science ®Google Scholar
• ChiccaAArenaCManeraCBeyond the direct activation of cannabinoid receptors: new strategies to modulate the endocannabinoid system in CNS-related diseasesRecent Pat CNS Drug Discov20161012214127630088
   PubMedGoogle Scholar
• TomaselliGValleeMStress and drug abuse-related disorders: the promising therapeutic value of neurosteroids focus on pregnenolone-progesterone-allopregnanolone pathwayFront Neuroendocrinol20195510078931525393
   PubMed Web of Science ®Google Scholar
• MaccarroneMBabIBiroTet alEndocannabinoid signaling at the periphery: 50 years after THCTrends Pharmacol Sci20153627729625796370
   PubMed Web of Science ®Google Scholar
• Busquets-GarciaAGomis-GonzalezMSrivastavaRKet alPeripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidationProc Natl Acad Sci 
U S A20161139904990927528659
   PubMed Web of Science ®Google Scholar
• Ruiz de AzuaIManciniGSrivastavaRKet alAdipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophagesJ Clin Invest20171274148416229035280
   PubMed Web of Science ®Google Scholar
• BellocchioLSoria-GomezEQuartaCet alActivation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockadeProc Natl Acad Sci U S A20131104786479123487769
   PubMed Web of Science ®Google Scholar
• SuarezJRiveraPAparisiRAet alAdipocyte cannabinoid CB1 receptor deficiency alleviates high fat diet-induced memory deficit, depressive-like behavior, neuroinflammation and impairment in adult neurogenesisPsychoneuroendocrinology201911010441831491589
   PubMed Web of Science ®Google Scholar
• PertweeRGHowlettACAboodMEet alInternational union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2Pharmacol Rev20106258863121079038
   PubMed Web of Science ®Google Scholar
• WoottenDChristopoulosAMarti-SolanoMBabuMMSextonPMMechanisms of signalling and biased agonism in G protein-coupled receptorsNat Rev Mol Cell Biol20181963865330104700
   PubMed Web of Science ®Google Scholar
• HanJKesnerPMetna-LaurentMet alAcute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTDCell20121481039105022385967
   PubMed Web of Science ®Google Scholar
• IlyasovAAMilliganCEPharrEPHowlettACThe endocannabinoid system and oligodendrocytes in health and diseaseFront Neurosci20181273330416422
   PubMed Web of Science ®Google Scholar
• AraujoDJTjoaKSaijoKThe endocannabinoid system as a window into microglial biology and its relationship to autismFront Cell Neurosci20191342431619967
   PubMed Web of Science ®Google Scholar
• CotaDSteinerMAMarsicanoGet alRequirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis functionEndocrinology20071481574158117194743
   PubMed Web of Science ®Google Scholar
• MarsicanoGLutzBExpression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrainEur J Neurosci1999114213422510594647
   PubMed Web of Science ®Google Scholar
• KatonaISperlághBSíkAet alPresynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneuronsJ Neurosci1999194544455810341254
   PubMed Web of Science ®Google Scholar
• ZouSKumarUColocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hippocampusBrain Res2015162211412626115586
   PubMed Web of Science ®Google Scholar
• KamprathKRomo-ParraHHäringMet alShort-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdalaNeuropsychopharmacology20113665266320980994
   PubMed Web of Science ®Google Scholar
• LangeMDDaldrupTRemmersFet alCannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threatMol Psychiatry2017221422143027698427
   PubMed Web of Science ®Google Scholar
• MonoryKMassaFEgertovaMet alThe endocannabinoid system controls key epileptogenic circuits in the hippocampusNeuron20065145546616908411
   PubMed Web of Science ®Google Scholar
• KatonaIUrbanGMWallaceMet alMolecular composition of the endocannabinoid system at glutamatergic synapsesJ Neurosci2006265628563716723519
   PubMed Web of Science ®Google Scholar
• Gutierrez-RodriguezABonilla-DelRIPuenteNet alLocalization of the cannabinoid type-1 receptor in subcellular astrocyte compartments of mutant mouse hippocampusGlia2018661417143129480581
   PubMed Web of Science ®Google Scholar
• BerrenderoFSepeNRamosJADi MarzoVFernandez-RuizJJAnalysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal periodSynapse19993318119110420166
   PubMed Web of Science ®Google Scholar
• Molina-HolgadoEVelaJMArevalo-MartinAet alCannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signalingJ Neurosci2002229742975312427829
   PubMed Web of Science ®Google Scholar
• GomezOSanchez-RodriguezMAOrtega-GutierrezSet alA basal tone of 2-arachidonoylglycerol contributes to early oligodendrocyte progenitor proliferation by activating phosphatidylinositol 3-kinase (PI3K)/AKT and the mammalian target of rapamycin (MTOR) pathwaysJ Neuroimmune Pharmacol20151030931725900077
   PubMed Web of Science ®Google Scholar
• AguadoTPalazuelosJMonoryKet alThe endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cellsJ Neurosci2006261551156116452678
   PubMed Web of Science ®Google Scholar
• ZimmermannTMarosoMBeerAet alNeural stem cell lineage-specific cannabinoid type-1 receptor regulates neurogenesis and plasticity in the adult mouse hippocampusCereb Cortex2018284454447130307491
   PubMed Web of Science ®Google Scholar
• LangeMDDaldrupTRemmersFet alCannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threatMol Psychiatry2017221422143027698427
   PubMed Web of Science ®Google Scholar
• Hebert-ChatelainEDesprezTSerratRet alA cannabinoid link between mitochondria and memoryNature201653955555927828947
   PubMed Web of Science ®Google Scholar
• RobinLMOliveira da CruzJFLanglaisVCet alAstroglial CB1 receptors determine synaptic D-serine availability to enable recognition memoryNeuron20189893594429779943
   PubMed Web of Science ®Google Scholar
• TanakaMSackettSZhangYEndocannabinoid modulation of microglial phenotypes in neuropathologyFront Neurol2020118732117037
   PubMed Web of Science ®Google Scholar
• JordanCJXiZXProgress in brain cannabinoid CB2 receptor research: from genes to behaviorNeurosci Biobehav Rev20199820822030611802
   PubMed Web of Science ®Google Scholar
• Van SickleMDDuncanMKingsleyPJet alIdentification and functional characterization of brainstem cannabinoid CB2 receptorsScience200531032933216224028
   PubMed Web of Science ®Google Scholar
• StempelAVStumpfAZhangHYet alCannabinoid type 2 receptors mediate a cell type-specific plasticity in the hippocampusNeuron20169079580927133464
   PubMed Web of Science ®Google Scholar
• ZhangHYGaoMLiuQRet alCannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in miceProc Natl Acad Sci U S A201411146E5007E501525368177
   PubMed Web of Science ®Google Scholar
• ZhangHYGaoMShenHet alExpression of functional cannabinoid CB2 receptor in VTA dopamine neurons in ratsAddict Biol20172275276526833913
   PubMed Web of Science ®Google Scholar
• YuSJReinerDShenHWuKJLiuQRWangYTime-dependent protection of CB2 receptor agonist in strokePLoS One201510e013248726186541
   PubMedGoogle Scholar
• KatonaIFreundTFMultiple functions of endocannabinoid signaling in the brainAnnu Rev Neurosci20123552955822524785
   PubMed Web of Science ®Google Scholar
• NyilasRDudokBUrbanGMet alEnzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminalsJ Neurosci2008281058106318234884
   PubMed Web of Science ®Google Scholar
• EgertovaMCravattBFElphickMRComparative analysis of fatty acid amide hydrolase and CB1 cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signalingNeuroscience200311948149612770562
   PubMed Web of Science ®Google Scholar
• GibsonHEEdwardsJGPageRSVan HookMJKauerJATRPV1 channels mediate long-term depression at synapses on hippocampal interneuronsNeuron20085774675918341994
   PubMed Web of Science ®Google Scholar
• GuggenhuberSRomo-ParraHBindilaLet alImpaired 2-AG signaling in hippocampal glutamatergic neurons: aggravation of anxiety-like behavior and unaltered seizure susceptibilityInt J Neuropsychopharmacol201519pyv09126232789
   PubMed Web of Science ®Google Scholar
• ZimmermannTBartschJCBeerAet alImpaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responsesNeuropsychopharmacology2019441377138830532004
   PubMed Web of Science ®Google Scholar
• BacciAHuguenardJRPrinceDALong-lasting self-inhibition of neocortical interneurons mediated by endocannabinoidsNature200443131231615372034
   PubMed Web of Science ®Google Scholar
• MarinelliSPacioniSCannichAMarsicanoGBacciASelf-modulation of neocortical pyramidal neurons by endocannabinoidsNat Neurosci2009121488149019915567
   PubMed Web of Science ®Google Scholar
• MarosoMSzaboGGKimHKet alCannabinoid control of learning and memory through HCN channelsNeuron2016891059107326898775
   PubMed Web of Science ®Google Scholar
• ThibaultKCarrelDBonnardDet alActivation-dependent subcellular distribution patterns of CB1 cannabinoid receptors in the rat forebrainCereb Cortex2013232581259122892424
   PubMed Web of Science ®Google Scholar
• Fletcher-JonesAHildickKLEvansAJNakamuraYWilkinsonKAHenleyJMThe C-terminal helix 9 motif in rat cannabinoid receptor type 1 regulates axonal trafficking and surface expressionElife20198
   PubMed Web of Science ®Google Scholar
• WickertMHildickKLBaillieGLet alThe F238L point mutation in the cannabinoid type 1 receptor enhances basal endocytosis via lipid raftsFront Mol Neurosci20181123030026687
   PubMed Web of Science ®Google Scholar
• SchneiderMKasanetzFLynchDLet alEnhanced functional activity of the cannabinoid type-1 receptor mediates adolescent behaviorJ Neurosci201535139751398826468198
   PubMed Web of Science ®Google Scholar
• DudokBBarnaLLedriMet alCell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signalingNat Neurosci201518758625485758
   PubMed Web of Science ®Google Scholar
• ImperatoreRMorelloGLuongoLet alGenetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB1R signaling and anxiety-like behaviorJ Neurochem201513579981326223500
   PubMed Web of Science ®Google Scholar
• CravattBFDemarestKPatricelliMPet alSupersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolaseProc Natl Acad Sci U S A2001989371937611470906
   PubMed Web of Science ®Google Scholar
• BenardGMassaFPuenteNet alMitochondrial CB1 receptors regulate neuronal energy metabolismNat Neurosci20121555856422388959
   PubMed Web of Science ®Google Scholar
• Jimenez-BlascoDBusquets-GarciaAHebert-ChatelainEet alGlucose metabolism links astroglial mitochondria to cannabinoid effectsNature2020583781760360832641832
   PubMed Web of Science ®Google Scholar
• AlgerBEKimJSupply and demand for endocannabinoidsTrends Neurosci20113430431521507493
   PubMed Web of Science ®Google Scholar
• KenakinTBiased receptor signaling in drug discoveryPharmacol Rev20197126731530914442
   PubMed Web of Science ®Google Scholar
• ZhaoPFurnessSGBThe nature of efficacy at G protein-coupled receptorsBiochem Pharmacol201917011364731585071
   PubMed Web of Science ®Google Scholar
• LaprairieRBBagherAMDenovan-WrightEMCannabinoid receptor ligand bias: implications in the central nervous systemCurr Opin Pharmacol201732324327835801
   PubMed Web of Science ®Google Scholar
• Al-ZoubiRMoralesPReggioPHStructural Insights into CB1 receptor biased signalingInt J Mol Sci20192081837
   PubMed Web of Science ®Google Scholar
• Borroto-EscuelaDOFuxeKOligomeric receptor complexes and their allosteric receptor-receptor interactions in the plasma membrane represent a new biological principle for integration of signals in the CNSFront Mol Neurosci20191223031607863
   PubMed Web of Science ®Google Scholar
• Borroto-EscuelaDOCarlssonJAmbroginiPet alUnderstanding the role of GPCR heteroreceptor complexes in modulating the brain networks in health and diseaseFront Cell Neurosci2017113728270751
   PubMed Web of Science ®Google Scholar
• Wager-MillerJWestenbroekRMackieKDimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an exampleChem Phys Lipids2002121838912505693
   PubMed Web of Science ®Google Scholar
• CallenLMorenoEBarroso-ChineaPet alCannabinoid receptors CB1 and CB2 form functional heteromers in brainJ Biol Chem2012287208512086522532560
   PubMed Web of Science ®Google Scholar
• NavarroGVaraniKReyes-ResinaIet alCannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1-CB2 heteroreceptor complexesFront Pharmacol2018963229977202
   PubMed Web of Science ®Google Scholar
• BagherAMLaprairieRBKellyMEDenovan-WrightEMAntagonism of dopamine receptor 2 long affects cannabinoid receptor 1 signaling in a cell culture model of striatal medium spiny projection neuronsMol Pharmacol20168965266627053685
   PubMed Web of Science ®Google Scholar
• BagherAMLaprairieRBToguriJTKellyMEMDenovan-WrightEMBidirectional allosteric interactions between cannabinoid receptor 1 (CB1) and dopamine receptor 2 long (D2L) heterotetramersEur J Pharmacol2017813668328734930
   PubMed Web of Science ®Google Scholar
• VinalsXMorenoELanfumeyLet alCognitive impairment induced by delta9-tetrahydrocannabinol occurs through heteromers between cannabinoid CB1 and serotonin 5-HT2A receptorsPLoS Biol201513e100219426158621
   PubMed Web of Science ®Google Scholar
• MorenoEChiarloneAMedranoMet alSingular location and signaling profile of adenosine A2A-cannabinoid CB1 receptor heteromers in the dorsal striatumNeuropsychopharmacology20184396497728102227
   PubMed Web of Science ®Google Scholar
• NavarroGVaraniKReyes-ResinaIet alCannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1-CB2 heteroreceptor complexesFront Pharmacol2018963229977202
   PubMed Web of Science ®Google Scholar
• Blasco-BenitoSMorenoESeijo-VilaMet alTherapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancerProc Natl Acad Sci 
U S A20191163863387230733293
   PubMed Web of Science ®Google Scholar
• GlassMFelderCCConcurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptorJ Neurosci199717532753339204917
   PubMed Web of Science ®Google Scholar
• KearnCSBlake-PalmerKDanielEMackieKGlassMConcurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor crosstalk?Mol Pharmacol2005671697170415710746
   PubMed Web of Science ®Google Scholar
• Caballero-FloranRNConde-RojasIOviedoCAet alCannabinoid-induced depression of synaptic transmission is switched to stimulation when dopaminergic tone is increased in the globus pallidus of the rodentNeuropharmacology201611040741827506997
   PubMed Web of Science ®Google Scholar
• NavarreteMAraqueAEndocannabinoids mediate neuron-astrocyte communicationNeuron20085788389318367089
   PubMed Web of Science ®Google Scholar
• MattheusTKuklaKZimmermannTTenzerSLutzBCell type-specific tandem affinity purification of the mouse hippocampal CB1 receptor-associated proteomeJ Proteome Res2016153585360127596989
   PubMed Web of Science ®Google Scholar
• Diez-AlarciaRIbarra-LecueILopez-CardonaAPet alBiased agonism of three different cannabinoid receptor agonists in mouse brain cortexFront Pharmacol2016741527867358
   PubMed Web of Science ®Google Scholar
• SteindelFLernerRHäringMet alNeuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampusJ Neurochem201312479580723289830
   PubMed Web of Science ®Google Scholar
• O’BrienJBWilkinsonJCRomanDLRegulator of G-protein signaling (RGS) proteins as drug targets: progress and future potentialsJ Biol Chem2019294185711858531636120
   PubMed Web of Science ®Google Scholar
• SongCAndersonGRSuttonLPDaoMMartemyanovKASelective role of RGS9-2 in regulating retrograde synaptic signaling of indirect pathway medium spiny neurons in dorsal striatumJ Neurosci2018387120713130006367
   PubMed Web of Science ®Google Scholar
• RaehalKMBohnLMThe role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeuticsNeuropharmacology201160586520713067
   PubMed Web of Science ®Google Scholar
• GurevichVVGurevichEVGPCR signaling regulation: the role of GRKs and arrestinsFront Pharmacol20191012530837883
   PubMed Web of Science ®Google Scholar
• Delgado-PerazaFAhnKHNogueras-OrtizCet alMechanisms of biased b-arrestin-mediated signaling downstream from the cannabinoid 1 receptorMol Pharmacol20168961862927009233
   PubMed Web of Science ®Google Scholar
• MorganDJDavisBJKearnCSet alMutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in miceJ Neurosci2014345152516324719095
   PubMed Web of Science ®Google Scholar
• YountsTJMondayHRDudokBet alPresynaptic protein synthesis is required for long-term plasticity of GABA releaseNeuron20169247949227764673
   PubMed Web of Science ®Google Scholar
• PuighermanalEMarsicanoGBusquets-GarciaALutzBMaldonadoROzaitaACannabinoid modulation of hippocampal long-term memory is mediated by mTOR signalingNat Neurosci2009121152115819648913
   PubMed Web of Science ®Google Scholar
• GuggenhuberSAlparAChenRet alCannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampusBrain Struct Funct20162212061207425772509
   PubMed Web of Science ®Google Scholar
• BoothWTWalkerNBLowtherWTHowlettACCannabinoid receptor interacting protein 1a CRIP1a: function and structureMolecules2019243672
   PubMed Web of Science ®Google Scholar
• RuehleSWager-MillerJStraikerAet alDiscovery and characterization of two novel CB1 receptor splice variants with modified N-termini in mouseJ Neurochem201714252153328608535
   PubMed Web of Science ®Google Scholar
• LiuQRHuangNSQuHet alIdentification of novel mouse and rat CB1R isoforms and in silico modeling of human CB1R for peripheral cannabinoid therapeuticsActa Pharmacol Sin20194038739730202012
   PubMed Web of Science ®Google Scholar
• RybergEVuHKLarssonNet alIdentification and characterisation of a novel splice variant of the human CB1 receptorFEBS Lett200557925926415620723
   PubMed Web of Science ®Google Scholar
• StraikerAWager-MillerJHutchensJMackieKDifferential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neuronesBr J Pharmacol20121652660267122014238
   PubMed Web of Science ®Google Scholar
• BagherAMLaprairieRBKellyMEDenovan-WrightEMCo-expression of the human cannabinoid receptor coding region splice variants (hCB1) affects the function of hCB1 receptor complexesEur J Pharmacol201372134135424091169
   PubMed Web of Science ®Google Scholar
• RapinoCCastellucciALizziARet alModulation of endocannabinoid-binding receptors in human neuroblastoma cells by tunicamycinMolecules2019241432
   PubMed Web of Science ®Google Scholar
• BondAMMingGLSongHAdult mammalian neural stem cells and neurogenesis: five decades laterCell Stem Cell20151738539526431181
   PubMed Web of Science ®Google Scholar
• TodaTParylakSLLinkerSBGageFHThe role of adult hippocampal neurogenesis in brain health and diseaseMol Psychiatry201924678729679070
   PubMed Web of Science ®Google Scholar
• MillerSMSahayAFunctions of adult-born neurons in hippocampal memory interference and indexingNat Neurosci2019221565157531477897
   PubMed Web of Science ®Google Scholar
• MaccarroneMGuzmanMMackieKDohertyPHarkanyTProgramming of neural cells by endocannabinoids: from physiological rules to emerging therapiesNat Rev Neurosci20141578680125409697
   PubMed Web of Science ®Google Scholar
• PrendervilleJAKellyAMDownerEJThe role of cannabinoids in adult neurogenesisBr J Pharmacol20151723950396325951750
   PubMed Web of Science ®Google Scholar
• OddiSScipioniLMaccarroneMEndocannabinoid system and adult neurogenesis: a focused reviewCurr Opin Pharmacol201950253231864101
   PubMed Web of Science ®Google Scholar
• GaoYVasilyevDVGoncalvesMBet alLoss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out miceJ Neurosci2010302017202420147530
   PubMed Web of Science ®Google Scholar
• JennichesITernesSAlbayramOet alAnxiety, stress, and fear response in mice with reduced endocannabinoid levelsBiol Psychiatry20167985886825981172
   PubMed Web of Science ®Google Scholar
• MenschingLDjogoNKellerCRadingSKarsakMStable adult hippocampal neurogenesis in cannabinoid receptor CB2 deficient miceInt J Mol Sci201920153759
   PubMed Web of Science ®Google Scholar
• PalazuelosJOrtegaZDiaz-AlonsoJGuzmanMGalve-RoperhICB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signalingJ Biol Chem20122871198120922102284
   PubMed Web of Science ®Google Scholar
• ZhangZWangWZhongPet alBlockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticityHippocampus201525162625131612
   PubMed Web of Science ®Google Scholar
• RodriguesRSRibeiroFFFerreiraFVazSHSebastiaoAMXapelliSInteraction between cannabinoid type 1 and type 2 receptors in the modulation of subventricular zone and dentate gyrus neurogenesisFront Pharmacol2017851628848435
   PubMed Web of Science ®Google Scholar
• JiangWZhangYXiaoLet alCannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effectsJ Clin Invest20051153104311616224541
   PubMed Web of Science ®Google Scholar
• WolfSABick-SanderAFabelKet alCannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesisCell Commun Signal201081220565726
   PubMed Web of Science ®Google Scholar
• CamposACOrtegaZPalazuelosJet alThe anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid systemInt J Neuropsychopharmacol2013161407141923298518
   PubMed Web of Science ®Google Scholar
• LeishmanEManchandaMThelenRMillerSMackieKBradshawHBCannabidiol’s upregulation of N-acyl ethanolamines in the central nervous system requires N-acyl phosphatidyl ethanolamine-specific phospholipase DCannabis Cannabinoid Res2018322824130515459
   PubMedGoogle Scholar
• HillMNTitternessAKMorrishACet alEndogenous cannabinoid signaling is required for voluntary exercise-induced enhancement of progenitor cell proliferation in the hippocampusHippocampus20102051352319489006
   PubMed Web of Science ®Google Scholar
• DubreucqSKoehlMAbrousDNMarsicanoGChaouloffFCB1 receptor deficiency decreases wheel-running activity: consequences on emotional behaviours and hippocampal neurogenesisExp Neurol201022410611320138171
   PubMed Web of Science ®Google Scholar
• Navarro-RomeroAVazquez-OliverAGomis-GonzalezMet alCannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndromeNeurobiol Dis20191259210630685352
   PubMed Web of Science ®Google Scholar
• KirdajovaDAnderovaMNG2 cells and their neurogenic potentialCurr Opin Pharmacol201950536031877531
   PubMed Web of Science ®Google Scholar
• KuhnSGrittiLCrooksDDombrowskiYOligodendrocytes in development, myelin generation and beyondCells201981424
   PubMed Web of Science ®Google Scholar
• GomezOSanchez-RodriguezALeMSanchez-CaroCMolina-HolgadoFMolina-HolgadoECannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin mTOR. pathwaysBr J Pharmacol20111631520153221480865
   PubMed Web of Science ®Google Scholar
• Bernal-ChicoACanedoMManterolaAet alBlockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivoGlia20156316317625130621
   PubMed Web of Science ®Google Scholar
• Tomas-RoigJAgbemenyahHYCelarainNQuintanaERamio-TorrentaLHavemann-ReineckeUDose-dependent effect of cannabinoid WIN-55,212-2 on myelin repair following a demyelinating insultSci Rep20201059031953431
   PubMed Web of Science ®Google Scholar
• Garcia-ArencibiaMMolina-HolgadoEMolina-HolgadoFEffect of endocannabinoid signalling on cell fate: life, death, differentiation and proliferation of brain cellsBr J Pharmacol20191761361136929797438
   PubMed Web of Science ®Google Scholar
• HurdYLManzoniOJPletnikovMVLeeFSBhattacharyyaSMelisMCannabis and the developing brain: insights into its long-lasting effectsJ Neurosci2019398250825831619494
   PubMed Web of Science ®Google Scholar
• FrauRMiczanVTraccisFet alPrenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenoloneNat Neurosci2019221975198531611707
   PubMed Web of Science ®Google Scholar
• de Salas-QuirogaAGarcia-RinconDGomez-DominguezDet alLong-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposureNeuropsychopharmacology20204587788631982904
   PubMed Web of Science ®Google Scholar
• RodriguesRSLourencoDMPauloSLet alCannabinoid actions on neural stem cells: implications for pathophysiologyMolecules2019241350
   PubMed Web of Science ®Google Scholar
• SipeJCChiangKGerberALBeutlerECravattBFA missense mutation in human fatty acid amide hydrolase associated with problem drug useProc Natl Acad Sci U S A2002998394839912060782
   PubMed Web of Science ®Google Scholar
• DinchevaIDrysdaleATHartleyCAet alFAAH genetic variation enhances fronto-amygdala function in mouse and humanNat Commun20156639525731744
   PubMed Web of Science ®Google Scholar
• MayoLMAsratianALindeJet alProtective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and miceMol Psychiatry202025993100530120421
   PubMed Web of Science ®Google Scholar
• GeeDGFetchoRNJingDet alIndividual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across speciesProc Natl Acad Sci U S A20161134500450527001846
   PubMed Web of Science ®Google Scholar
• HabibAMOkorokovALHillMNet alMicrodeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivityBr J Anaesth2019123e249e25330929760
   PubMed Web of Science ®Google Scholar
• KongXMiaoQLuXet alThe association of endocannabinoid receptor genes (CNR1 and CNR2) polymorphisms with depression: a meta-analysisMedicine (Baltimore)201998e1740331725603
   PubMed Web of Science ®Google Scholar
• LazaryJEszlariNJuhaszGBagdyGA functional variant of CB2 receptor gene interacts with childhood trauma and FAAH gene on anxious and depressive phenotypesJ Affect Disord201925771672231382124
   PubMed Web of Science ®Google Scholar
• HillardCJCirculating endocannabinoids: from whence do they come and where are they going?Neuropsychopharmacology20184315517228653665
   PubMed Web of Science ®Google Scholar
• Muller-VahlKRBindilaLLutzBet alCerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndromeNeuropsychopharmacology2020451323132932272483
   PubMed Web of Science ®Google Scholar
• KranasterLHoyerCMindtSet alThe novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluidEur Arch Psychiatry Clin Neurosci2019 Nov 23 Epub ahead of print https://doi.org/10.1007/s00406-019-01086-x
   Web of Science ®Google Scholar
• SloanMEGrantCWGowinJLRamchandaniVALe FollBEndocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studiesActa Pharmacol Sin20194034235030166624
   PubMed Web of Science ®Google Scholar
• RussoEBCannabis therapeutics and the future of neurologyFront Integr Neurosci2018125130405366
   PubMed Web of Science ®Google Scholar
• SarrisJSinclairJKaramacoskaDDavidsonMFirthJMedicinal cannabis for psychiatric disorders: a clinically-focused systematic reviewBMC Psychiatry2020202431948424
   PubMed Web of Science ®Google Scholar
• BlackNStockingsECampbellGet alCannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysisLancet Psychiatry20196995101031672337
   PubMed Web of Science ®Google Scholar
• NomuraDKMorrisonBEBlankmanJLet alEndocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammationScience201133480981322021672
   PubMed Web of Science ®Google Scholar
• GomesIGrushkoJSGolebiewskaUet alNovel endogenous peptide agonists of cannabinoid receptorsFASEB J2009233020302919380512
   PubMed Web of Science ®Google Scholar
• BauerMChiccaATamborriniMet alIdentification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptorsJ Biol Chem2012287369443696722952224
   PubMed Web of Science ®Google Scholar
• WeiFZhaoLJingYSignaling molecules targeting cannabinoid receptors: hemopressin and related peptidesNeuropeptides20207910199831831183
   PubMed Web of Science ®Google Scholar
• ChristensenRKristensenPKBartelsEMBliddalHAstrupAEfficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trialsLancet20073701706171318022033
   PubMed Web of Science ®Google Scholar
• AmatoGKhanNSMaitraRA patent update on cannabinoid receptor 1 antagonists (2015-2018)Expert Opin Ther Pat20192926126930889997
   PubMed Web of Science ®Google Scholar
• KhuranaLMackieKPiomelliDKendallDAModulation of CB1 cannabinoid receptor by allosteric ligands: pharmacology and therapeutic opportunitiesNeuropharmacology201712431228527758
   PubMed Web of Science ®Google Scholar
• SlivickiRAXuZKulkarniPMet alPositive allosteric modulation of cannabinoid receptor type 1 suppresses pathological pain without producing tolerance or dependenceBiol Psychiatry20188472273328823711
   PubMed Web of Science ®Google Scholar
• SlivickiRAIyerVMaliSSet alPositive allosteric modulation of CB1 cannabinoid receptor signaling enhances morphine antinociception and attenuates morphine tolerance without enhancing morphine-induced dependence or rewardFront Mol Neurosci2020135432410959
   PubMed Web of Science ®Google Scholar
• TomaselliGValleeMStress and drug abuse-related disorders: the promising therapeutic value of neurosteroids focus on pregnenolone-progesterone-allopregnanolone pathwayFront Neuroendocrinol20195510078931525393
   PubMed Web of Science ®Google Scholar
• PetrucciVChiccaAGlasmacherSet alPepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damageSci Rep20177956028842619
   PubMed Web of Science ®Google Scholar
• IyerMRCinarRKatzAet alDesign, synthesis, and biological evaluation of novel, non-brain-penetrant, hybrid cannabinoid CB1R inverse agonist/inducible nitric oxide synthase (iNOS) inhibitors for the treatment of liver fibrosisJ Med Chem2017601126114128085283
   PubMed Web of Science ®Google Scholar
• XuBXiaoJXuKet alVF-13, a chimeric peptide of VD-hemopressin(α) and neuropeptide VF, produces potent antinociception with reduced cannabinoid-related side effectsNeuropharmacology202010817832544481
   PubMed Web of Science ®Google Scholar
• MoralesPGoyaPJagerovicNEmerging strategies targeting CB2 cannabinoid receptor: biased agonism and allosterismBiochem Pharmacol201815781730055149
   PubMed Web of Science ®Google Scholar
• FazioDCriscuoloEPiccoliABarboniBFezzaFMaccarroneMAdvances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold?Expert Opin Drug Discov2020114
   Web of Science ®Google Scholar
• Gil-OrdonezAMartin-FontechaMOrtega-
GutierrezSLopez-RodriguezMLMonoacylglycerol lipase (MAGL) as a promising therapeutic targetBiochem Pharmacol2018157183230059673
   PubMed Web of Science ®Google Scholar
• BedseGHillMNPatelS2-Arachidonoylglycerol modulation of anxiety and stress adaptation: from grass roots to novel therapeuticsBiol Psychiatry2020S0006-322320300494
   Google Scholar
• RenSYWangZZZhangYChenNHPotential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases-focusing on FAAH/MAGL inhibitorsActa Pharmacol Sin2020 Mar 18 Epub ahead of print https://doi.org/10.1038/s41401-020-0385-7
   Web of Science ®Google Scholar
• VozellaVAhmedFChoobchianPet alPharmacokinetics, pharmacodynamics and safety studies on URB937, a peripherally restricted fatty acid amide hydrolase inhibitor, in ratsJ Pharm Pharmacol2019711762177331579946
   PubMed Web of Science ®Google Scholar
• D’SouzaDCCortes-BrionesJCreaturaGet alEfficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trialLancet Psychiatry20196354530528676
   PubMed Web of Science ®Google Scholar
• MayoLMAsratianALindeJet alElevated anandamide, enhanced recall of fear extinction, and attenuated stress responses following inhibition of fatty acid amide hydrolase: a randomized, controlled experimental medicine trialBiol Psychiatry20208753854731590924
   PubMed Web of Science ®Google Scholar
• van EsbroeckACMJanssenAPACognettaAB IIIet alActivity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474Science20173561084108728596366
   PubMed Web of Science ®Google Scholar
• MockEDMustafaMGunduz-CinarOet alDiscovery of a NAPE-PLD inhibitor that modulates emotional behavior in miceNat Chem Biol20201666767532393901
   PubMed Web of Science ®Google Scholar
• NicolussiSGertschJEndocannabinoid transport revisitedVitam Horm20159844148525817877
   PubMed Web of Science ®Google Scholar
• ChiccaANicolussiSBartholomausRet alChemical probes to potently and selectively inhibit endocannabinoid cellular reuptakeProc Natl Acad Sci U S A2017114E5006E501528584105
   PubMed Web of Science ®Google Scholar
• Reynoso-MorenoIChiccaAFlores-SotoMEViveros-ParedesJMGertschJThe endocannabinoid reuptake inhibitor WOBE437 is orally bioavailable and exerts indirect polypharmacological effects via different endocannabinoid receptorsFront Mol Neurosci20181118029910713
   PubMed Web of Science ®Google Scholar
• ShenCJZhengDLiKXet alCannabinoid CB1 receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behaviorNat Med20192533734930643290
   PubMed Web of Science ®Google Scholar
• MarcusDJBedseGGauldenADet alEndocannabinoid signaling collapse mediates stress-induced amygdalo-cortical strengtheningNeuron20201051062107631948734
   PubMed Web of Science ®Google Scholar
• HermannMStillhardPWildnerHet alBinary recombinase systems for high-resolution conditional mutagenesisNucleic Acids Res2014423894390724413561
   PubMed Web of Science ®Google Scholar
• MadisenLGarnerARShimaokaDet alTransgenic mice for intersectional targeting of neural sensors and effectors with high specificity and performanceNeuron20158594295825741722
   PubMed Web of Science ®Google Scholar
• KarimovaMBakerOCamgozANaumannRBuchholzFAnastassiadisKA single reporter mouse line for Vika, Flp, Dre, and Cre-recombinationSci Rep201881445330262904
   PubMed Web of Science ®Google Scholar
• YaoSYuanPOuelletteBet alRecV recombinase system for in vivo targeted optogenomic modifications of single cells or cell populationsNat Methods20201742242932203389
   PubMed Web of Science ®Google Scholar
• ShalemOSanjanaNEZhangFHigh-throughput functional genomics using CRISPR-Cas9Nat Rev Genet20151629931125854182
   PubMed Web of Science ®Google Scholar
• NavabpourSKwapisJLJaromeTJA neuroscientist’s guide to transgenic mice and other genetic toolsNeurosci Biobehav Rev202010873274831843544
   PubMed Web of Science ®Google Scholar
• ArlottaPPascaSPCell diversity in the human cerebral cortex: from the embryo to brain organoidsCurr Opin Neurobiol20195619419831051421
   PubMed Web of Science ®Google Scholar
• SidhayeJKnoblichJABrain organoids: an ensemble of bioassays to investigate human neurodevelopment and diseaseCell Death Differ2020 Jun 1 Epub ahead of print https://doi.org/10.1038/s41418-020-0566-4
   PubMed Web of Science ®Google Scholar
• FischerJHeideMHuttnerWBGenetic modification of brain organoids. Front Cell Neurosci20191355831920558
   PubMed Web of Science ®Google Scholar
• AoZCaiHHavertDJet alOne-stop microfluidic assembly of human brain organoids to model prenatal cannabis exposureAnal Chemi20209246304638
   PubMed Web of Science ®Google Scholar
• VelascoSKedaigleAJSimmonsSKet alIndividual brain organoids reproducibly form cell diversity of the human cerebral cortexNature201957052352731168097
   PubMed Web of Science ®Google Scholar